Investigation of the effect of Interleukin-1 receptor antagonist (IL-1ra) on markers of inflammation in non-ST elevation acute coronary syndromes The MRC-ILA-HEART Study

Randomisation system log-in to secure server here

The MRC-ILA-HEART Study is a proof of concept clinical trial investigating the effects of IL-1ra upon markers of inflammation in patients with Non-ST elevation myocardial infarction. It is hoped this will provide new and exciting information in relation to an anti-inflammatory strategy for patients with acute coronary syndrome.

ISRCTN 89369318

Contact information:

Clinical Trials & Evaluation Unit
Britten Street Wing
Royal Brompton Hospital
Sydney Street
London SW3 6NP

Email: c.foley@rbht.nhs.uk

Randomisation service provided by: Sealed Envelope™.com